XML 21 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Revenue:      
Product $ 9,620 $ 5,988 $ 2,253
Service 530 411 12
Grant 240 0 894
Total revenue 10,390 6,399 3,159
Cost of revenue:      
Product 12,673 8,176 8,173
Service 1,871 975 14
Total cost of revenue 14,544 9,151 8,187
Gross margin (4,154) (2,752) (5,028)
Operating expenses:      
Research and development 10,449 9,404 8,780
Selling and marketing 5,139 4,681 3,781
General and administrative 21,685 14,742 9,508
Total operating expenses 37,273 28,827 22,069
Loss from operations (41,427) (31,579) (27,097)
Interest income 2 1 4
Interest expense (3,452) (2,243) (97)
Other income (expense), net (117) 21 (32)
Loss before provision for income taxes (44,994) (33,800) (27,222)
Provision for income taxes 1 0 0
Net loss (44,995) (33,800) (27,222)
Cumulative dividends on convertible preferred stock 0 0 (2,898)
Deemed capital conversion of Series C convertible preferred stock into common stock 0 0 8,783
Deemed dividend on convertible preferred stock extinguishment 0 0 (6,863)
Deemed capital contribution on repurchase of Series A preferred stock 0 9 0
Net loss attributable to common stockholders $ (44,995) $ (33,791) $ (28,200)
Net loss per share attributable to common stockholders, basic and diluted $ (2.58) $ (37.87) $ (34.59)
Weighted-average common shares used to compute net loss per share attributable to common stockholders, basic and diluted 17,432,434 892,315 815,340